Keyphrases
Abiraterone
16%
Androgen Deprivation Therapy
16%
Androgen Receptor Targeted Therapy
16%
Androgens
16%
Beneficial Role
16%
Biobank
16%
Biomarker Discovery
16%
Biomarker Validation
16%
Clinical Practice
16%
Disease Progression
16%
Dysregulation
16%
Emotional Quality
16%
Energy Metabolism
16%
Enzalutamide
16%
Ethics
16%
Ethics Approval
33%
Evidence Support
16%
Exercise Medicine
16%
Exercise Prescription
16%
High-intensity Exercise
33%
High-intensity Resistance Exercise
16%
High-intensity Resistance Training
16%
Immune Function
16%
Inflammation
16%
Insulin Metabolism
16%
Intense Exercise
100%
International Conference
16%
Mechanism of Action
16%
Metabolic Biomarkers
16%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
100%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
16%
National Conference
16%
Nave
16%
New Biomarkers
16%
Opiate Use
16%
Overall Survival
66%
Pain Level
16%
Patient's Will
16%
Peer-reviewed Journals
16%
Phase II Study
100%
Physical Activity
16%
Physical Quality
16%
Prior Chemotherapy
16%
Progressive Disease
16%
Prostate Cancer Outcomes
16%
Psychosocial Support
16%
Quality of Life
16%
Randomized Controlled Trial
33%
Self-directed Exercise
16%
Skeletal-related Events
16%
Supervised Exercise
16%
Treatment Site
16%
Treatment Status
16%
Medicine and Dentistry
Abiraterone
12%
Aerobic Exercise
12%
Androgen
12%
Androgen Deprivation Therapy
12%
Androgen Receptor
12%
Biological Marker
37%
Disease Exacerbation
12%
Energy Metabolism
12%
Enzalutamide
12%
Immune Function
12%
Insulin Metabolism
12%
Medicine
12%
Opiate
12%
Overall Survival
50%
Patient History of Chemotherapy
12%
Physical Activity
12%
Progressive Disease
12%
Prostate Cancer
100%
Psychosocial Care
12%
Quality of Life
12%
Randomized Controlled Trial
25%
Resistance Training
25%
Targeted Therapy
12%